Journal Logo

Secondary Logo

 

Log in to view full text. If you're not a subscriber, you can:

You can read the full text of this article if you:

-- Select an option --

Institutional members access full text with Ovid®

Share this article on:

Risperidone as Monotherapy for a Patient With Obsessive Compulsive Disorder Comorbid With Schizoaffective Disorder: A Case Report.

Chiou, Yu-Jie MD; Lin, Pao-Yen MD, PhD; Lee, Yu MD, MS
Clinical Neuropharmacology: Post Author Corrections: May 13, 2015
doi: 10.1097/WNF.0000000000000079
Case Report: PDF Only

Data on the efficacy of antipsychotics as monotherapy for obsessive-compulsive disorder (OCD) are inadequate. This report presents the case of a patient with OCD that was successfully treated with risperidone as monotherapy. Assessments revealed significant reductions in OCD symptoms after risperidone treatment (4 mg/d). This report suggests the beneficial effect of risperidone for a patient with OCD comorbid with schizoaffective disorder.

Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.